T'SHEIRA SCOTT: Open Payments
NPI 1790438877 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 52 payments from 28 companies in 2025. Trend: 2023 $120 · 2024 $668 · 2025 $1,213
Food & beverage: $1,163Education: $50
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $172 |
| Janssen Biotech, Inc. | 5 | $104 |
| Dexcom, Inc. | 2 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| ABBVIE INC. | 2 | $64 |
| Genentech USA, Inc. | 3 | $59 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Geron Corporation | 2 | $45 |
| Daiichi Sankyo Inc. | 2 | $41 |
Products named: SCEMBLIX, Dexcom G6 Transmitter, VENCLEXTA, ERLEADA, OPDIVO, DARZALEX, Fabhalta, ZYNLONTA.
Industry payments across SC — which companies pay providers there.
